Cutler Group LP Precigen, Inc. Call Options Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 Apr 14, 2022	SELL	$1.91 - $3.98 $15,089 - $31,442	-7,900 Reduced 94.05%	500 $0
Q4 2021 Jan 18, 2022	BUY	$3.53 - $5.5 $1,765 - $2,750	500 Added 6.33%	8,400 $1,000
Q3 2021 Oct 26, 2021	BUY	$4.99 - $6.55 $19,960 - $26,200	4,000 Added 102.56%	7,900 $3,000
Q2 2021 Jul 19, 2021	SELL	$6.24 - $8.22 $38,688 - $50,964	-6,200 Reduced 61.39%	3,900 $0
Q1 2020 May 07, 2020	BUY	$1.46 - $7.19 $14,746 - $72,619	10,100 New	10,100 $4,000

141

161M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $271M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.